# In silico analysis of hypo-upregulated genes as biomarkers in lung adenocarcinoma

## TL;DR

This study identifies genes that are both hypomethylated and upregulated in lung adenocarcinoma, suggesting potential new biomarkers for the disease.

## Contribution

The integration of methylation and expression data to identify 'Hypo-Up' genes as novel biomarker candidates in LUAD.

## Key findings

- 7313 methylated and 250 upregulated genes were identified in LUAD.
- Hypo-Up genes show hypomethylation and elevated expression, indicating possible carcinogenic roles.
- The study highlights significant epigenetic and transcriptome abnormalities in LUAD.

## Abstract

Lung adenocarcinoma (LUAD), the most common kind of lung cancer, is characterized by altered gene expression and DNA methylation.
This study used TCGA to evaluate methylation and expression data from LUAD. Differential analysis revealed 7313 methylated genes and 250
upregulated genes. Integration identified "Hypo-Up" genes, which are hypomethylated and elevated, indicating carcinogenic potential.
Further protein-protein interaction studies will reveal important seed genes. Data shows severe epigenetic and transcriptome
abnormalities in LUAD and suggest new biomarker possibilities.